Silencing of lncRNA maternally expressed gene 3 (MEG3) attenuated sex hormone dysregulation and ovarian histopathological changes in rats with PCOS and promoted follicle cell development and maturation by targeting the miR-21-3p/PI3K/AKT/mTOR pathway. This evidence concerns the gene MTOR and polycystic ovary syndrome.